Macarena I. de la Fuente

Ivosidenib in Isocitrate Dehydrogenase 1<i>–</i>Mutated Advanced Glioma

Ingo K. Mellinghoff, Benjamin M. Ellingson, Mehdi Touat et al. · Journal of Clinical Oncology · 2020 · 307 citations · Full text

Medicine, Oncology, Pharmacology +16

Integration of 2-hydroxyglutarate-proton magnetic resonance spectroscopy into clinical practice for disease monitoring in isocitrate dehydrogenase-mutant glioma

Macarena I. de la Fuente, Robert J. Young, Jennifer Rubel et al. · Neuro-Oncology · 2015 · 194 citations

Medicine, Oncology, Radiology +17

BRAF–MEK Inhibition in Newly Diagnosed Papillary Craniopharyngiomas

Priscilla K. Brastianos, Erin Twohy, Susan Geyer et al. · New England Journal of Medicine · 2023 · 135 citations · Full text

Medicine, Oncology, Radiation Oncology +14

Efficacy and Determinants of Response to HER Kinase Inhibition in <i>HER2</i> -Mutant Metastatic Breast Cancer

Lillian M. Smyth, Sarina A. Piha‐Paul, Helen Won et al. · Cancer Discovery · 2019 · 108 citations · Full text

Medicine, Oncology, Pharmacology +17

Risk Factors for Transformation to Higher-Grade Lymphoma and Its Impact on Survival in a Large Cohort of Patients With Marginal Zone Lymphoma From a Single Institution

Juan Pablo Alderuccio, Wei Zhao, Amrita Desai et al. · Journal of Clinical Oncology · 2018 · 79 citations

Medicine, Oncology, Pathology +10